Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Companies / Health Care / Life Sciences Tools & Services

Thermo Fisher Scientific stock buybacks

TMO
$5.0Bbought back in the 12 months to Jun 27, 2026

Thermo Fisher Scientific bought back $5.0B of its stock in the last twelve months, $4.7B more than it paid out in stock compensation. Its share count is down 1.9% from a year earlier.

Stock repurchases by quarter
$0$1.5B$3BQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q2 '26
Show as table
PeriodValue
Q3 '20$0
Q4 '20$0
Q1 '21$2B
Q2 '21$0
Q3 '21$0
Q4 '21$0
Q1 '22$2B
Q2 '22$0
Q3 '22$0
Q4 '22$1B
Q1 '23$3B
Q2 '23$0
Q3 '23$0
Q4 '23$0
Q1 '24$3B
Q2 '24$0
Q3 '24$0
Q4 '24$1B
Q1 '25$2B
Q2 '25$0
Q3 '25$963M
Q4 '25$37M
Q1 '26$3B
Q2 '26$1B
Diluted shares outstanding
372.3M385.0M397.7MQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q3 '25Q2 '26
Show as table
PeriodValue
Q3 '20399.0M
Q4 '20399.0M
Q1 '21397.0M
Q2 '21396.0M
Q3 '21397.0M
Q4 '21398.0M
Q1 '22395.0M
Q2 '22394.0M
Q3 '22395.0M
Q4 '22392.0M
Q1 '23388.0M
Q2 '23388.0M
Q3 '23388.0M
Q4 '23388.0M
Q1 '24384.0M
Q2 '24383.0M
Q3 '24384.0M
Q4 '24381.0M
Q1 '25379.0M
Q2 '25378.0M
Q3 '25378.0M
Q4 '25377.0M
Q1 '26373.0M
Q2 '26371.0M
$1.0Blast quarter (Q2 2026)
$4.7Bnet of stock compensation ($319M)
−1.9%diluted shares, 1 year
−5.3%diluted shares, 5 years
$662Mdividends, 12 months
68%of free cash flow ($7.3B) spent on buybacks
$0raised by issuing stock, 12 months
369.7Mshares outstanding (Jun 27, 2026)

By fiscal year

Fiscal yearBuybacksDividendsStock payFree cash flowDiluted sharesFiling
2025$3.0B$636M$310M$6.3B378.0M10-K
2024$4.0B$583M$301M$7.3B383.0M10-K
2023$3.0B$523M$278M$6.9B388.0M10-K
2022$3.0B$455M$307M$6.9B394.0M10-K
2021$2.0B$395M$230M$6.8B397.0M10-K
2020$1.5B$337M$196M$6.8B399.0M10-K
2019$1.5B$297M$181M$4.0B403.0M10-K
2018$500M$266M$181M$3.8B406.0M10-K
2017$750M$237M$159M$3.5B398.0M10-K
2016$1.3B$238M$133M$2.8B397.0M10-K

Questions

Does Thermo Fisher Scientific buy back its stock?
Thermo Fisher Scientific bought back $5.0B of its stock in the last twelve months, $4.7B more than it paid out in stock compensation. Its share count is down 1.9% from a year earlier.
How much did Thermo Fisher Scientific spend on buybacks in fiscal 2025?
$3.0B, according to its 10-K for the fiscal year ending Dec 31, 2025.
Is Thermo Fisher Scientific's share count going down?
Its diluted share count changed −5.3% over five fiscal years and −1.9% over the last year.

Latest filing used: 10-Q for the period ending Jun 27, 2026, filed Jul 31, 2026 · open on SEC.gov

Other Health Care companies